293780.KQ
AptaBio Therapeutics Inc.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,620.00
+4.91%Margins
Gross margin
43.2%
EBITDA margin
-481.7%
EBIT margin
-386.8%
Net margin
-312.9%
FCF margin
-366.2%
-35.2%
Return on equity
-27.3%
Return on assets
-39.0%
Return on invested capital
0.09x
Asset turnover
-KRW 17.4B
Cash from operations
KRW 576
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026